How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.

Stacchiotti S, Pantziarka P, Leonard H, Voltz C, Abatedaga L, Bouche G, Bouygues C, Bovee JVMG, Van der Graaf WTA, Rojas T, D'Ambrosio L, Donoghue M, Enzmann H, Feeney G, Foggi P, Frezza AM, Herold R, Jones RL, Kasper B, Roes K, Marreaud S, Miceli R, Robinson D, Sommer J, Tap WD, Tydings C, Trama A, Houdt WV, van Oortmerssen G, Wagner AJ, Widemann B, Gelderblom H, Gronchi A, Napolitano A, Dufresne A, Fumagalli ER, Baldi G, Marquina G, Koseła-Paterczyk H, Martin Javier JB, Junker N, Rutkowski P, Oyen WJG, Lacombe D, Pignatti F, Demolis P

Open source

DOI
10.1016/j.ctrv.2025.103003
Published
2025 Nov
Container
Cancer treatment reviews
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctrv.2025.103003,
  title = {How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.},
  author = {Stacchiotti S and Pantziarka P and Leonard H and Voltz C and Abatedaga L and Bouche G and Bouygues C and Bovee JVMG and Van der Graaf WTA and Rojas T and D'Ambrosio L and Donoghue M and Enzmann H and Feeney G and Foggi P and Frezza AM and Herold R and Jones RL and Kasper B and Roes K and Marreaud S and Miceli R and Robinson D and Sommer J and Tap WD and Tydings C and Trama A and Houdt WV and van Oortmerssen G and Wagner AJ and Widemann B and Gelderblom H and Gronchi A and Napolitano A and Dufresne A and Fumagalli ER and Baldi G and Marquina G and Koseła-Paterczyk H and Martin Javier JB and Junker N and Rutkowski P and Oyen WJG and Lacombe D and Pignatti F and Demolis P},
  year = {2025},
  journal = {Cancer treatment reviews},
  doi = {10.1016/j.ctrv.2025.103003},
  url = {https://doi.org/10.1016/j.ctrv.2025.103003}
}

RIS

TY  - JOUR
TI  - How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
AU  - Stacchiotti S
AU  - Pantziarka P
AU  - Leonard H
AU  - Voltz C
AU  - Abatedaga L
AU  - Bouche G
AU  - Bouygues C
AU  - Bovee JVMG
AU  - Van der Graaf WTA
AU  - Rojas T
AU  - D'Ambrosio L
AU  - Donoghue M
AU  - Enzmann H
AU  - Feeney G
AU  - Foggi P
AU  - Frezza AM
AU  - Herold R
AU  - Jones RL
AU  - Kasper B
AU  - Roes K
AU  - Marreaud S
AU  - Miceli R
AU  - Robinson D
AU  - Sommer J
AU  - Tap WD
AU  - Tydings C
AU  - Trama A
AU  - Houdt WV
AU  - van Oortmerssen G
AU  - Wagner AJ
AU  - Widemann B
AU  - Gelderblom H
AU  - Gronchi A
AU  - Napolitano A
AU  - Dufresne A
AU  - Fumagalli ER
AU  - Baldi G
AU  - Marquina G
AU  - Koseła-Paterczyk H
AU  - Martin Javier JB
AU  - Junker N
AU  - Rutkowski P
AU  - Oyen WJG
AU  - Lacombe D
AU  - Pignatti F
AU  - Demolis P
PY  - 2025
JO  - Cancer treatment reviews
DO  - 10.1016/j.ctrv.2025.103003
UR  - https://doi.org/10.1016/j.ctrv.2025.103003
ER  -

APA

S, S., P, P., H, L., C, V., L, A., G, B., C, B., JVMG, B., WTA, V. D. G., T, R., L, D., M, D., H, E., G, F., P, F., AM, F., R, H., RL, J., B, K., K, R., S, M., R, M., D, R., J, S., WD, T., C, T., A, T., WV, H., G, V. O., AJ, W., B, W., H, G., A, G., A, N., A, D., ER, F., G, B., G, M., H, K., JB, M. J., N, J., P, R., WJG, O., D, L., F, P., & P, D. (2025). How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.. Cancer treatment reviews. https://doi.org/10.1016/j.ctrv.2025.103003

Source records